Skip to content

Author

Charlie Li

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Clinical Pharmacokinetics and Disposition of Imrecoxib

Current evidence is limited by small, mainly single-dose studies, predominantly Chinese populations, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2.

Sheng-Nan Zhao, Charlie Li, Marlon C. Mallillin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.